Picture of Zentalis Pharmaceuticals logo

ZNTL — Zentalis Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Zentalis Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

* Zentalis Pharmaceuticals Inc  ZNTL.OQ  reported a
quarterly
adjusted loss of $1.24​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.85.  The mean expectation of eleven analysts
for the quarter was for a loss of 84 cents per share. Wall
Street expected results to range from -98 cents to -47 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Zentalis Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of $1.24​.
    * The company reported a quarterly loss of $88.28 million.
    * Zentalis Pharmaceuticals Inc shares had fallen by 19.1%
this
quarter and lost 78.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Zentalis
Pharmaceuticals Inc is $8.50 
This summary was machine generated from LSEG data August 9 at
01:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.84          -1.24          Missed
 Mar. 31 2024      -0.77          0.14           Beat
 Dec. 31 2023      -0.92          -0.93          Missed
 Sep. 30 2023      -0.91          -0.79          Beat

Recent news on Zentalis Pharmaceuticals

See all news